Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment

被引：46
|
作者：
Terao, Toshiki [1 ,2 ]
Minami, Yosuke [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan
[2] Kameda Med Ctr, Dept Internal Med, Div Hematol Oncol, Kamogawa 2968602, Japan
来源：
CELLS | 2019年 / 8卷 / 04期
关键词：
Hedgehog pathway; acute myeloid leukemia; AML; leukemic stem cell; glioma; Smoothened; glasdegib; sonidegib; STEM-CELLS; MYELODYSPLASTIC SYNDROME; GLASDEGIB PF-04449913; CLINICAL-IMPLICATIONS; PHASE IB; GLI; INHIBITOR; MUTATIONS; ACTIVATION; THERAPY;
D O I：
10.3390/cells8040312
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are important for the tumor cells' cycle or therapeutic resistance of AML cells. In this article, we will review the current trends in Hh pathway inhibitors for treating AML.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure
    Lainez-Gonzalez, Daniel
    Serrano-Lopez, Juana
    Alonso-Dominguez, Juan Manuel
    BIOLOGY-BASEL, 2021, 10 (04):
  • [42] Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs
    Chiarella, Emanuela
    Nistico, Clelia
    Di Vito, Anna
    Morrone, Helen Linda
    Mesuraca, Maria
    BIOMEDICINES, 2022, 10 (05)
  • [43] Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia
    Puissant, Alexandre
    Fenouille, Nina
    Bassil, Christopher F.
    Ben-Sahra, Issam
    Benajiba, Lina
    Alexe, Gabriela
    Ramos, Azucena
    Pikman, Yana
    Burgess, Michael R.
    Li, Qing
    Luciano, Frederic
    Auberger, Patrick
    Galinsky, Ilene
    DeAngelo, Daniel J.
    Stone, Richard M.
    Perkins, Archibald S.
    Shannon, Kevin
    Hemann, Michael T.
    Stegmaier, Kimberly
    BLOOD, 2016, 128 (22)
  • [44] Targeting Cholesterol Homeostasis Pathway to Overcome Acquired Cytarabine Resistance in Acute Myeloid Leukemia
    Das, Saswati
    Illangeswaran, Raveen Stephen Stallon
    Jebanesan, Daniel Zechariah Paul Zechariah Paul
    Vidhyadharan, Rakhi Thalayatta
    Mathews, Vikram
    Velayudhan, Shaji Ramachandran
    Balasubramanian, Poonkuzhali
    BLOOD, 2022, 140 : 11543 - 11543
  • [45] Treatment of acute myeloid leukemia
    Burnett, AK
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18): : 1438 - 1439
  • [46] Treatment of acute myeloid leukemia
    Estey, Elihu H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 10 - 16
  • [47] TREATMENT OF ACUTE MYELOID LEUKEMIA
    FRIEND, JH
    GILES, C
    RICHARDSON, SG
    JOURNAL OF CLINICAL PATHOLOGY, 1974, 27 (01) : 53 - 54
  • [48] Targeting transcription factors in acute myeloid leukemia
    Takei, Hisashi
    Kobayashi, Susumu S.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 28 - 34
  • [49] Targeting the Acute Myeloid Leukemia Stem Cells
    Krause, Alexandre
    Fontanari Krause, Luciana M.
    Rego, Eduardo M.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (02) : 104 - 110
  • [50] Targeting transcription factors in acute myeloid leukemia
    Hisashi Takei
    Susumu S. Kobayashi
    International Journal of Hematology, 2019, 109 : 28 - 34
12345